INDIANAPOLIS (Inside INdiana Business) -- Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the U.S. government has made another purchase of 614,000 doses of the combination bamlanivimab and etesevimab antibody therapy for COVID-19. As part of the nearly $1.3 billion purchase, Lilly says it will deliver the doses no later than January 31.
Rolls-Royce Corp. in Indianapolis is partnering with Anderson-based startup ChefsFridge Co. to develop a novel way to store and transport COVID-19 vaccines.
Renew Indianapolis has received more than $3.6 million in federal COVID-19 Rapid Response funds.
Children 12 and older can now receive the [...]
As more and more people get vaccinated, something [...]
Much of the Latinx population has been hesitant [...]
Pfizer isn't the only company seeking to lower the age limit for its vaccine.
The Indiana Office of Community and Rural Affairs has announced the recipients of nearly $19 million in federal funding through its COVID-19 Response Grant Program.
A team of Purdue University scientists is using its expertise in tracking the spread of malaria in Africa to track COVID-19 in Indiana.
New Jersey-based Catalent Inc. (NYSE: CTLT) is ramping up production of the Moderna Inc. (Nasdaq: MRNA) COVID-19 vaccine at its facility in Bloomington.
